- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05790512
Association of Oral Helicobacter Pylori Infection With Gastric Helicobacter Pylori Infection
August 3, 2023 updated by: Yongquan Shi, Xijing Hospital of Digestive Diseases
The aim of this study was to investigate the association between oral Helicobacter pylori infection and gastric Helicobacter pylori infection.
Patients who were tested for gastric Helicobacter pylori were tested for oral Helicobacter pylori at the same time, and were divided into four groups according to the test results to compare the positive rate of oral Helicobacter pylori.
Study Overview
Status
Completed
Conditions
Study Type
Observational
Enrollment (Actual)
500
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Jiaojiao Cao
- Phone Number: : +86-15029258646
- Email: 2119811879@qq.com
Study Locations
-
-
Shaanxi
-
Xi'an, Shaanxi, China, 710032
- Xijing Hosipital of Digestive Disease
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 70 years (Adult, Older Adult)
Accepts Healthy Volunteers
Yes
Sampling Method
Non-Probability Sample
Study Population
patients are from Xijing Hospital.
Description
Inclusion Criteria:
- Age between 18~70 ,both gender.
- Initial diagnosis of stomach Helicobacter pylori infection or never had Helicobacter pylori infection.
- Have not received dental care or systemic periodontal basic treatment in the past 1 year.
Exclusion Criteria:
- There is serious organ damage and complications (such as cirrhosis, uremia, etc.), severe or unstable cardiopulmonary or endocrine diseases.
- Ongoing use of antiulcer medications (including PPIs taken within 2 weeks before Helicobacter pylori infection testing), antibiotics, or bismuth complexes (more than 3 times/week before screening).
- Those with severe oral diseases and malignant tumors of the mouth.
- Previously had upper gastrointestinal surgery.
- Refusal to sign informed consent.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
---|
Both gastric and oral Helicobacter pylori are negative
|
Negative for Helicobacter pylori for gastric and positive for Helicobacter pylori for oral cavity
|
Positive for Helicobacter pylori for gastric and negative for Helicobacter pylori for oral cavity
|
Both gastric and oral Helicobacter pylori are positive
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Positive rate of oral Helicobacter pylori
Time Frame: 7 months
|
The oral Helicobacter pylori test is performed using the Helicobacter pylori test kit
|
7 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Study Director: Yongquan Shi, PhD, Xijing Hosipital of Digestive Disease
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
November 22, 2022
Primary Completion (Actual)
August 1, 2023
Study Completion (Actual)
August 1, 2023
Study Registration Dates
First Submitted
March 17, 2023
First Submitted That Met QC Criteria
March 17, 2023
First Posted (Actual)
March 30, 2023
Study Record Updates
Last Update Posted (Actual)
August 4, 2023
Last Update Submitted That Met QC Criteria
August 3, 2023
Last Verified
August 1, 2023
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- KY20232027-C-1-A
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Helicobacter Pylori
-
ImevaXCompletedHelicobacter Pylori Infected Subjects | Helicobacter Pylori Naive SubjectsGermany
-
Bangabandhu Sheikh Mujib Medical University, Dhaka...RecruitingHelicobacter Pylori Infection | Helicobacter Pylori EradicationBangladesh
-
Fu Jen Catholic University HospitalActive, not recruitingHelicobacter PyloriTaiwan
-
Poitiers University HospitalCompleted
-
Shandong UniversityUnknownHelicobacter PyloriChina
-
Hamamatsu UniversityOita UniversityUnknownHelicobacter PyloriJapan
-
National Liver Institute, EgyptFuture pharmaceutical industriesRecruitingHelicobacter PyloriEgypt
-
Hillel Yaffe Medical CenterNot yet recruiting